Daidzein Attenuates Busulfan-Induced Premature Ovarian Insufficiency Through Coordinated Modulation of Redox Homeostasis, Inflammatory and Apoptotic Signaling: A Comparative animal Study
Background Premature ovarian insufficiency (POI) is a major complication of gonadotoxic chemotherapy that impairs fertility and endocrine function. Busulfan induces ovarian injury through oxidative stress, inflammation, and apoptosis. Although daidzein exhibits antioxidant and phytoestrogenic properties, its efficacy relative to estradiol has not been comprehensively evaluated in busulfan-induced POI. This study compared the protective effects of daidzein and estradiol on ovarian structure, function, biomarkers and the expression of core genes involved in the three pathways previously mentioned. Methods Thirty female Sprague-Dawley rats were assigned to Control, daidzein, busulfan-induced POI, POI+ daidzein, or POI+estradiol groups (n = 6). Treatments continued for 50 days after busulfan administration. The stereological analysis assessed the ovarian morphology and follicle numbers. Oxidative stress biomarkers (SOD, CAT, TAC, and MDA) in ovarian tissue and estradiol, progesterone, TNF-α concentration in serum were measured using commercial kits. Expression of ovarian genes (Nrf2, FOXL2, ERα, ERβ, BCL2, CASP3, and TNF-α ) was evaluated using Real-Time PCR. Results Busulfan significantly reduced ovarian stereological indices, healthy follicle counts, SOD and CAT activity, TAC, estradiol and progesterone concentration, and the expression of Nrf2, FOXL2, ERα, ERβ, and BCL2 genes , while increasing atretic follicles, MDA, TNF-α, and CASP3 genes expression ( P < 0.05). Daidzein significantly improved ovarian morphology, follicular preservation, antioxidant status, hormone levels, and the expression of Nrf2, FOXL2, and BCL2 genes, while reducing MDA, TNF-α, and CASP3 gene expression ( P < 0.05). Estradiol improved ovarian morphology, estradiol level, SOD activity, TAC and, the expression of Nrf2, BCL2, and CASP3 genes, while did not significantly affect CAT activity, progesterone level and FOXL2, or TNF-α genes expression. Conclusion Daidzein partially protected against busulfan-induced POI by preserving ovarian morphology, endocrine function, antioxidant defenses, and molecular pathways regulating oxidative stress, inflammation, apoptosis, and estrogen signaling. These findings support daidzein as a promising adjunctive strategy for ovarian protection during chemotherapy and warrant further mechanistic and translational investigation.
Authors
- Fatemeh Asadian (ORCID: https://orcid.org/0000-0002-5421-7761)
- Fatemeh Zal (ORCID: https://orcid.org/0000-0002-7078-4854)
- Farhad Koohpeyma (ORCID: https://orcid.org/0000-0001-6729-7732)
- Sanaz Alaee (ORCID: https://orcid.org/0000-0003-4490-8830)
- Naeimehossadat Asmarian (ORCID: https://orcid.org/0000-0001-6091-8890)
- Fatemeh Rahimi (ORCID: https://orcid.org/0000-0002-6513-0469)
- Fatemeh Khademi (ORCID: https://orcid.org/0000-0002-1854-4343)
Institutions
- Shiraz University of Medical Sciences (IR)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11246461/v1
- Primary Topic
- Reproductive Biology and Fertility
- Type
- preprint